2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

Neuropsychological assessment in a cohort of patients with Parkinson’s disease

C. Juri, W. Uslar, H. Farias, M. Vasquez (Santiago, Chile)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease

G. Santangelo, F. Falco, M. Vicidomini, R. Allocca, P. Barone, C. Vitale (Caserta, Italy)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Neuropsychological subgroups in non-demented Parkinson’s disease: A latent class analysis

L. Brennan, K. Devlin, S.X. Xie, D. Mechanic-Hamilton, B. Tran, H. Hurtig, A. Chen-Plotkin, L. Chahine, J.F. Morley, J.E. Duda, D.R. Roalf, N. Dahodwala, J. Rick, J.Q. Trojanowski, P.J. Moberg, D. Weintraub (Philadelphia, PA, USA)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Neuropsychology and magnetic resonance correlation in Parkinson´s disease mild cognitive impairment: Case-control study

L.F.R. Vasconcellos, M. Adachi, D. Greca, M. Cruz, A.L. Malak, H. Charchat-Fichman, J.S. Pereira (Rio de Janeiro, Brazil)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease

G. Marti, N. Saez, M. Corominas, G. Cuberas, C. Lorenzo, O. De Fabregues, J. Alvarez-Sabin, M. Casas, J. Hernandez (Barcelona, Spain)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Novel variants in the SACS gene in a first Central-Eastern European family with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)

M. Schinwelski, M. Krygier, J. Slawek, M. Zuk, M. Rydzanicz, A. Walczak, P. Stawinski, A. Konkel, M. Sildatke-Bauer, R. Ploski, J. Limon (Gdansk, Poland)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Objective, unobtrusive assessment of bradykinesia in Parkinson’s disease

P.J.M. Bank, J. Marinus, J.H. de Groot, C.G.M. Meskers, J.J. van Hilten (Leiden, Netherlands)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Occurrence and pattern of cognitive deficits in prodromal Parkinson’s disease

C. Pausch, J. Spiegel, F.A. Wollenweber, C. Bayer, U. Dillmann, K. Fassbender, S. Behnke (Homburg Saar, Germany)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Olfaction analysis in spinocerebellar ataxia type 10 and type 3 comparing with healthy controls and PD

M. Moscovich, A. Moro, R. Munhoz, H.G. Teive, L.S. Moryiama (Curitiba, Brazil)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2